Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 451–465 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3768 CFHR5 Gene Hemolytic Uremic Syndrome Genetic Test This test identifies pathogenic variants in the CFHR5 gene associated with atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy.	Whole blood (EDTA) or extracted genomic DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CFHR5 gene", "Copy number variations (CNV) in the CFHR5 gene"] Parameters [] Preparation ["No fasting required", "Prior genetic counselling session mandatory to document family history"] Indications ["Diagnosis of atypical hemolytic uremic syndrome (aHUS)", "Diagnosis of C3 glomerulopathy", "Family risk assessment for aHUS and C3 glomerulopathy"] Measurement technique Confirm with laboratory Codes LOINC: 21673-3 ICD-10: D59.3 Clinical summary This test identifies pathogenic variants in the CFHR5 gene associated with atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy.
TEST-3806 CFI Gene Hemolytic Uremic Syndrome (HUS) Genetic Test This test evaluates the entire coding region of the CFI gene for pathogenic variants associated with complement-mediated atypical hemolytic uremic syndrome (aHUS).	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CFI gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Pre-genetic counselling is mandatory.", "Document a three-generation pedigree."] Indications ["Suspected atypical hemolytic uremic syndrome (aHUS)", "Family history of aHUS", "Need for genetic predisposition assessment for lifelong management"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: D59.32 Clinical summary This test evaluates the entire coding region of the CFI gene for pathogenic variants associated with complement-mediated atypical hemolytic uremic syndrome (aHUS).
TEST-5301 CFL2 Gene Nemaline Myopathy Type 7 Genetic Test This test evaluates the CFL2 gene for mutations associated with Nemaline Myopathy Type 7.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CFL2 gene sequence variants"] Parameters [] Preparation [] Indications ["Suspected Nemaline Myopathy Type 7", "Family history of Nemaline Myopathy Type 7", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.2 Clinical summary This test evaluates the CFL2 gene for mutations associated with Nemaline Myopathy Type 7.
TEST-3468 CFTR Gene Congenital Bilateral Absence of Vas Deferens (CBAVD) NGS Test This diagnostic test evaluates the CFTR gene for pathogenic variants associated with congenital bilateral absence of the vas deferens (CBAVD), a common cause of male infertility.	Blood or Extracted DNA (Peripheral Whole Blood)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CFTR gene pathogenic variants", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Diagnosis of CBAVD", "Evaluation of male infertility", "Genetic counseling for reproductive options"] Measurement technique Confirm with laboratory Codes LOINC: 21656-1 ICD-10: Q55.4 Clinical summary This diagnostic test evaluates the CFTR gene for pathogenic variants associated with congenital bilateral absence of the vas deferens (CBAVD), a common cause of male infertility.
TEST-4449 CHD2 Gene Epileptic Encephalopathy, Childhood‑Onset Genetic Test This genetic test identifies pathogenic variants in the CHD2 gene associated with childhood-onset epileptic encephalopathy.	Whole blood (peripheral), extracted DNA, or FTA card spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHD2 gene", "Coverage of entire coding region + 20 bp exon-intron boundaries"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Children with suspected CHD2-related epileptic encephalopathy", "Early-onset seizures with developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 82324-3 ICD-10: G40.4, G40.9, G31.9 Clinical summary This genetic test identifies pathogenic variants in the CHD2 gene associated with childhood-onset epileptic encephalopathy.
TEST-2684 CHD7 Gene Analysis for Kallmann Syndrome Type 5 (Genetic Test) This test evaluates the CHD7 gene for mutations associated with Kallmann syndrome type 5, a condition characterized by impaired sense of smell and delayed or absent puberty.	Blood, FTA card, extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHD7 gene sequence", "Copy Number Variants (CNVs) in CHD7 gene"] Parameters [] Preparation [] Indications ["Suspected Kallmann syndrome type 5", "Evaluation of hypogonadotropic hypogonadism with anosmia", "Genetic counseling for families with Kallmann syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E23.0 Clinical summary This test evaluates the CHD7 gene for mutations associated with Kallmann syndrome type 5, a condition characterized by impaired sense of smell and delayed or absent puberty.
TEST-2973 CHD7 Gene CHARGE Syndrome Genetic Test This test evaluates the CHD7 gene for pathogenic variants associated with CHARGE syndrome.	Buccal Swab or Peripheral Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHD7 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions (within 30 days)"] Indications ["Infants and children presenting with clinical features suggestive of CHARGE syndrome", "Carrier testing for parents of affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 96369-9 ICD-10: Q87.8 Clinical summary This test evaluates the CHD7 gene for pathogenic variants associated with CHARGE syndrome.
TEST-3892 CHD8 Gene Autism Susceptibility Type 18 Genetic Test This genetic test identifies pathogenic variants within the CHD8 gene, which are associated with specific forms of autism spectrum disorder.	Peripheral whole blood (EDTA) or saliva (Oragene DNA collection kit)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHD8 gene"] Parameters [] Preparation [] Indications ["Confirmed autism diagnosis", "Unexplained developmental delay", "Intellectual disability", "Documented family history suggestive of CHD8-related neurodevelopmental conditions"] Measurement technique Confirm with laboratory Codes LOINC: 82320-4 ICD-10: F84.0 Clinical summary This genetic test identifies pathogenic variants within the CHD8 gene, which are associated with specific forms of autism spectrum disorder.
TEST-3788 CHGB Gene ALS Risk Factor Genetic Test This test evaluates the CHGB gene for pathogenic variants associated with an increased risk of developing Amyotrophic Lateral Sclerosis (ALS).	Peripheral Whole Blood	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHGB gene", "Genetic susceptibility to ALS"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Individuals with a family history of ALS", "Assessment of genetic risk for ALS", "Genetic counselling for individuals concerned about ALS risk"] Measurement technique Confirm with laboratory Codes LOINC: 81208-0 ICD-10: Z13.89 Clinical summary This test evaluates the CHGB gene for pathogenic variants associated with an increased risk of developing Amyotrophic Lateral Sclerosis (ALS).
TEST-5158 CHKB Gene Congenital Megaconial Muscular Dystrophy Genetic Test This genetic test evaluates the CHKB gene for pathogenic variants associated with congenital megaconial muscular dystrophy.	Whole Blood, Dried Blood Spot (FTA Card), Extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHKB gene coding region variants", "Pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current anticoagulant therapy"] Indications ["Suspected congenital megaconial muscular dystrophy", "Family history of the condition", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 94856-0 ICD-10: G71.2 Clinical summary This genetic test evaluates the CHKB gene for pathogenic variants associated with congenital megaconial muscular dystrophy.
TEST-2964 CHM Gene Choroideremia Genetic Test This genetic test analyzes the CHM gene for mutations associated with choroideremia, an inherited eye disorder causing progressive vision loss.	Peripheral whole blood (EDTA) or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHM gene", "Copy Number Variations (CNV) in the CHM gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of suspected choroideremia", "Carrier screening for individuals with a family history", "Family planning for affected families", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92811-6 ICD-10: H31.21 Clinical summary This genetic test analyzes the CHM gene for mutations associated with choroideremia, an inherited eye disorder causing progressive vision loss.
TEST-5512 CHMP1A Gene Pontocerebellar Hypoplasia Type 8 (PCH8) Genetic Test This test identifies pathogenic variants in the CHMP1A gene associated with Pontocerebellar Hypoplasia Type 8 (PCH8). It uses Next-Generation Sequencing (NGS) for comprehensive ana...	Whole Blood (2-3 mL), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHMP1A gene coding regions", "CHMP1A gene splice sites", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required.", "Continue prescribed medications unless advised otherwise by your doctor."] Indications ["Suspected diagnosis of Pontocerebellar Hypoplasia Type 8 (PCH8)", "Family history of PCH8", "Genetic counselling for recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 98052-2 ICD-10: Q04.3, Z13.42, Z82.79 Clinical summary This test identifies pathogenic variants in the CHMP1A gene associated with Pontocerebellar Hypoplasia Type 8 (PCH8). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-3778 CHMP2B Gene Amyotrophic Lateral Sclerosis Type 17 (ALS17) Genetic Test This genetic test identifies pathogenic variants in the CHMP2B gene associated with Amyotrophic Lateral Sclerosis Type 17 (ALS17). It confirms the molecular basis of the condition.	Peripheral Whole Blood (3–5 mL in EDTA tube) or FTA Card DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHMP2B gene", "Presence of mutations causing ALS17"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected diagnosis of ALS17", "Family history of ALS17", "Differential diagnosis of motor neuron disease"] Measurement technique Confirm with laboratory Codes LOINC: 94845-8 ICD-10: G12.21 Clinical summary This genetic test identifies pathogenic variants in the CHMP2B gene associated with Amyotrophic Lateral Sclerosis Type 17 (ALS17). It confirms the molecular basis of the condition.
TEST-4771 CHRNA1 Gene Analysis for Multiple Pterygium Syndrome (Lethal Type) Test This test identifies pathogenic variants in the CHRNA1 gene associated with lethal multiple pterygium syndrome.	Peripheral whole blood (EDTA), extracted genomic DNA, or dried blood spot (FTA card)	3–4 weeks (expedited available for prenatal cases)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHRNA1 gene", "Copy Number Variants (CNVs) in the CHRNA1 gene"] Parameters [] Preparation [] Indications ["Suspected diagnosis of lethal multiple pterygium syndrome (LMPS)", "Family history of LMPS", "Prenatal diagnosis in high-risk pregnancies"] Measurement technique Confirm with laboratory Codes LOINC: 81265-5 ICD-10: Q79.8 Clinical summary This test identifies pathogenic variants in the CHRNA1 gene associated with lethal multiple pterygium syndrome.
TEST-4369 CHRNA2 Gene Sequencing: Nocturnal Frontal Lobe Epilepsy Type 4 Test This test evaluates the CHRNA2 gene for pathogenic variants associated with autosomal dominant nocturnal frontal lobe epilepsy type 4 (ENFL4). It uses next-generation sequencing (N...	Whole Blood (3–5 mL EDTA), Extracted DNA (≥1 µg), or FTA Card Dried Blood Spot	21–28 Business Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHRNA2 gene", "Coding sequence and flanking intronic boundaries of CHRNA2"] Parameters [] Preparation ["No special dietary preparation or medication withdrawal is needed.", "Standard peripheral whole blood sample (3–5 mL in EDTA) required."] Indications ["Suspected diagnosis of autosomal dominant nocturnal frontal lobe epilepsy type 4 (ENFL4)", "Family history of ENFL4", "Need for genetic counselling regarding ENFL4 risk"] Measurement technique Confirm with laboratory Codes LOINC: 98557-8 ICD-10: G40.0, G40.809 Clinical summary This test evaluates the CHRNA2 gene for pathogenic variants associated with autosomal dominant nocturnal frontal lobe epilepsy type 4 (ENFL4). It uses next-generation sequencing (NGS) to provide comprehensive coverage of the gene.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories